Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
Jialang Zhuang,1,2,* Siqi Chen,1,3,* Ye Hu,1 Fan Yang,1 Qin Huo,1 Ni Xie1 1Biobank, Shenzhen Second People’s Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, People’s Republic of China; 2Shenzhen Institute of Advanced Technology, Chinese Academy of Sc...
Guardado en:
Autores principales: | Zhuang J, Chen S, Hu Y, Yang F, Huo Q, Xie N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6edf984760ae447999638bd7c08423b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release
por: Hakeem A, et al.
Publicado: (2018) -
Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang D, et al.
Publicado: (2017) -
Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery
por: Prabhakar N, et al.
Publicado: (2016) -
Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms
por: Lu MM, et al.
Publicado: (2018) -
EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
por: Li Y, et al.
Publicado: (2017)